Novavax Stock Rockets After Covid Vaccine Proves 96.4% Effective In TestingInvestors Business Daily • 03/12/21
Novavax's COVID-19 vaccine was 89.7% effective in a large trial, and worked against the contagious virus variant first found in the UKBusiness Insider • 03/12/21
Novavax Coronavirus Vaccine Candidate Shows 96% Efficacy With Original Strain, 86% Against U.K. VariantThe Motley Fool • 03/12/21
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa TrialsPRNewsWire • 03/11/21